medicines

Vaccine hope driven by data from Novavax and J&J, but fears about new variants remain

Novavax’s stock rises as its Covid-19 vaccine outpaces J&J

The self-destructive struggle for vaccines in Europe – WSJ

Pfizer Covid-19 vaccine works against mutations found in the UK, South Africa variants, laboratory study results

EU clashes with AstraZeneca over Covid-19 vaccine deficit

Some doctors warn against taking painkillers before receiving the COVID-19 vaccine

The shape-shifting virus threatens disease cycles and blockages

It was a dark morning in the Covid-19 fight. The market is looking for hope at Johnson & Johnson.

Merck Scrap Covid-19 Vaccine Candidates

California officials investigate death of person who received the Covid-19 vaccine hours earlier

Fauci says Johnson & Johnson’s COVID-19 vaccine could get approval in two weeks

Johnson & Johnson targets 100 million doses of vaccine by spring. The stock market is counting on that.